Ana Vladu, MD
Geriatric Medicine · Tinton Falls, NJNPI 1851524722
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 99 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 22.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $908 and has fallen 66.6% since, to $303 in 2025.
Across 99 payments — averaging $20.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$453
- AstraZeneca$439
- Pfizer$299
- Amarin Pharma, Inc.$143
- Lilly USA, LLC$92
- Amgen$88
- plus $501 from 15 others
What the payments were for
- Food & beverage$2,016100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 24 | $453 |
| AstraZeneca | 8 | $439 |
| Pfizer | 15 | $299 |
| Amarin Pharma, Inc. | 11 | $143 |
| Lilly USA, LLC | 6 | $92 |
| Amgen(2 entities) | 6 | $88 |
| Lundbeck LLC | 3 | $54 |
| Teva Pharmaceuticals USA, Inc. | 3 | $54 |
| Exact Sciences | 2 | $51 |
| Alk-abello, Inc | 3 | $47 |
| Novo Nordisk | 3 | $43 |
| E.r. Squibb & Sons, L.L.C. | 3 | $41 |
| Otsuka America Pharmaceutical, Inc. | 2 | $36 |
| Boston Scientific | 1 | $34 |
| Nestle Healthcare Nutrition Inc. | 2 | $29 |
| Merck | 2 | $27 |
| Bayer | 1 | $26 |
| Neurocrine Biosciences, Inc. | 1 | $17 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $16 |
| Novartis | 1 | $14 |
| Eisai Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,016 in reported general payments places this provider in the 80th percentile of 165 geriatric medicine providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 166 | $168,937 |
| EliquisApixaban | 305 | $129,626 |
| CreonLipase/Protease/Amylase | 39 | $110,112 |
| EntrestoSacubitril/Valsartan | 119 | $83,569 |
| JanuviaSitagliptin Phosphate | 118 | $70,749 |
| FarxigaDapagliflozin Propanediol | 97 | $59,723 |
| TriumeqAbacavir/Dolutegravir/Lamivudi | 12 | $47,540 |
| JardianceEmpagliflozin | 50 | $38,464 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 38 | $32,806 |
| OzempicSemaglutide | 18 | $26,999 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 29 | $23,999 |
| Breo ElliptaFluticasone/Vilanterol | 30 | $15,083 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 108 | $14,923 |
| RestasisCyclosporine | 30 | $14,487 |
| VascepaIcosapent Ethyl | 66 | $13,969 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity | $92 | $168,937166 claims |
| AbbVieCreon, Restasis, Linzess | $453 | $137,41982 claims |
| PfizerEliquis | $299 | $129,626305 claims |
| MerckJanuvia, Janumet Xr, Janumet | $27 | $109,839172 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $439 | $83,721126 claims |
| NovartisEntresto | $14 | $83,569119 claims |
| Novo NordiskOzempic, Fiasp | $43 | $30,75630 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 165 geriatric medicine providers in New Jersey.
Other geriatric medicine in Tinton Falls
- Albert RiddleHaworth$524K
- Gamil MakarClifton$82K
- Joshua Shua HaimManchester$45K
- Pradip ShahWest Caldwell$27K
- Gregorio GuillenPerth Amboy$8K
- Ketankumar VaidyaEdison$8K
- Cheng-An MaoClifton$8K
- Theresa RedlingLivingston$7K
- Sarita RastogiHackensack$7K
- Leslie FeiginDenville$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.